Hedge Funds Flock to SmallCap Biotech Potential Opportunities in Emerging Drug Developers CLX Q1 2026 Earnings EPS Beats Estimates Amid Volume Recovery Shares Slide State Crackdown on Prediction Markets Escalates Regulatory Turmoil